DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 2Dr. Reddy's Laboratories
02 1Olpha
03 36AstraZeneca
04 1Cipla
05 2Olon S.p.A
06 2Pinnacle Life Science
07 1Sandoz B2B
08 2TherDose Pharma
01 1CAPSULE;ORAL
02 1Capsule
03 1Capsule, hard
04 6Film Coated Tablet
05 1Olaparib 50Mg 448 Unita' Oral Use
06 2Oral Solid Dosage Form
07 2TAB
08 4TABLET
09 2TABLET;ORAL
10 3Tablet
11 2Tablets
12 22Blank
01 2Allowed
02 2Approved
03 1Available Dossier- US-EU-RoW
04 1DISCN
05 1Deregistered
06 1Dossier Readiness:Q3 2026
07 2Lead Market Dossiers- Under Development
08 2Originator
09 2RX
10 33Blank
01 5LYNPARZA
02 29Lynparza
03 1Lynparza 100
04 1Lynparza 150
05 2OLAPARIB
06 2Olaparib
07 7Blank
01 22Australia
02 2Canada
03 6India
04 3Italy
05 1Latvia
06 1Norway
07 2South Africa
08 3Sweden
09 2Switzerland
10 5USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Under Development
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Under Development
Registration Country : India
Olpha, a JSC AB City subsidiary, is a leading Baltic firm with 50 years of experience in medicines & chemical pharmaceuticals.
Regulatory Info : Dossier Readiness:Q3 2026
Registration Country : Latvia
Brand Name :
Dosage Form : Tablet
Dosage Strength :
Packaging :
Approval Date :
Application Number :
Regulatory Info : Dossier Readiness:Q3 2026
Registration Country : Latvia
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Under Development
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 150MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Under Development
Registration Country : India
Regulatory Info : DISCN
Registration Country : USA
Brand Name : LYNPARZA
Dosage Form : CAPSULE;ORAL
Dosage Strength : 50MG
Packaging :
Approval Date : 2014-12-19
Application Number : 206162
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : LYNPARZA
Dosage Form : TABLET;ORAL
Dosage Strength : 100MG
Packaging :
Approval Date : 2017-08-17
Application Number : 208558
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : LYNPARZA
Dosage Form : TABLET;ORAL
Dosage Strength : 150MG
Packaging :
Approval Date : 2017-08-17
Application Number : 208558
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : Italy
Brand Name : Lynparza
Dosage Form : Olaparib 50Mg 448 Unita' Oral Use
Dosage Strength : 448 cps 50 mg vial
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Norway
Brand Name : Lynparza
Dosage Form : Capsule, hard
Dosage Strength : 50 mg
Packaging : Bottle
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Canada
Brand Name : LYNPARZA
Dosage Form : TABLET
Dosage Strength : 100MG
Packaging : 60/120
Approval Date :
Application Number : 2475200
Regulatory Info :
Registration Country : Canada
Regulatory Info :
Registration Country : Canada
Brand Name : LYNPARZA
Dosage Form : TABLET
Dosage Strength : 150MG
Packaging : 60/120
Approval Date :
Application Number : 2475219
Regulatory Info :
Registration Country : Canada
Regulatory Info :
Registration Country : Australia
Brand Name : Lynparza
Dosage Form :
Dosage Strength :
Packaging : 56
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Regulatory Info :
Registration Country : Australia
Brand Name : Lynparza
Dosage Form :
Dosage Strength :
Packaging : 56
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Regulatory Info :
Registration Country : Australia
Brand Name : Lynparza
Dosage Form :
Dosage Strength :
Packaging : 56
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Regulatory Info :
Registration Country : Australia
Brand Name : Lynparza
Dosage Form :
Dosage Strength :
Packaging : 56
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Regulatory Info :
Registration Country : USA
Brand Name : OLAPARIB
Dosage Form : TABLET
Dosage Strength : 150MG
Packaging :
Approval Date :
Application Number : 219410
Regulatory Info :
Registration Country : USA
Regulatory Info : Available Dossier- US-EU-RoW
Registration Country : Italy
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Available Dossier- US-EU-RoW
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 150MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : USA
Brand Name : OLAPARIB
Dosage Form : TABLET
Dosage Strength : 150MG
Packaging :
Approval Date :
Application Number : 217936
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Tablets
Dosage Strength : 100mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Tablets
Dosage Strength : 150mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
